 AIM ImmunoTech Inc NYSEAMERICAN:AIM announced Wednesday that it ended 2020 with cash, cash equivalents, and marketable securities of 54.4 million. Thats a sizable increase compared to the 8.8 million in cash it recorded as of December 31, 2019, according to a statement. 